Mar 22 | Mar 21 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 96.58B | $ 112.47B | $ 108.19B | $ 21.87M | $ 934.49K |
Total Assets | $ 13.18T | $ 12.91T | $ 13.79T | $ 112.84M | $ 73.06M |
Total Debt | $ 4.35T | $ 4.64T | $ 5.75T | $ 26.48M | $ 7.03M |
Net Debt | $ 4.25T | $ 4.52T | $ 5.64T | $ 4.61M | $ 6.09M |
Total Liabilities | $ 7.49T | $ 7.74T | $ 8.61T | $ 45.68M | $ 27.51M |
Stockholders Equity | $ 5.68T | $ 5.17T | $ 5.18T | $ 67.16M | $ 45.56M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |